Learn more

ANDROMACO LAB

Overview
  • Total Patents
    43
  • GoodIP Patent Rank
    188,450
About

ANDROMACO LAB has a total of 43 patent applications. Its first patent ever was published in 1990. It filed its patents most often in Spain, Japan and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, macromolecular chemistry and polymers and biotechnology are GALECTIN THERAPEUTICS INC, ARC MEDICAL DEVICES INC and EURAND PHARMACEUTICALS LTD.

Patent filings per year

Chart showing ANDROMACO LABs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Pivel Ranieri Juan Pablo 11
#2 Chen Shu-Chen 10
#3 Guerrero Gomez-Pamo Antonio 8
#4 Guerrero Gomez-Pamo Antonio F 4
#5 Beltran Apablaza Marianela Del Carmen 4
#6 Carrasco Llamas Luis 4
#7 Guerrero Benito Carmen 4
#8 Leal Ojeda Juan Antonio 3
#9 Campos Perez German Arzobindo 3
#10 Morales Urzua Marcos 3

Latest patents

Publication Filing date Title
UY34554A VAGINAL RING INCLUDING MELOXICAM AND A MODULATING AGENT FOR THE RELEASE OF THE ACTIVE PRINCIPLE, USEFUL AS AN ANTI-CONCEPT FOR CONTINUOUS USE IN WOMEN
WO2013098591A1 Vaginal ring including meloxicam and an agent for modulating the release of the active principle, which can be used as a continuous-use contraceptive in women
WO2012014012A1 Method for producing tablets that dissolve rapidly in the mouth and that include form i of olanzapine, resulting tablets and use thereof in the treatment of schizophrenia
MX2008010082A Pharmaceutical composition in encapsulated powders comprising orlistat, process for preparing the composition and use thereof for treating obesity.
JPH06217772A Preparation of polypeptide type product having inhibitive action against excessive production of tumor necrosis factor
ES2038546A1 PROCEDURE FOR OBTAINING A PRODUCT OF A POLYPEPTIDIC NATURE WITH INHIBITING ACTIVITY OF THE HYPERPRODUCTION OF THE TUMOR NECROSIS FACTOR.
ES2049561A1 PROCEDURE FOR OBTAINING POLYMERS WITH ACTIVITY ON THE HEMATOPOYETIC SYSTEM.
ES2027518A6 A process for preparing new non-covalent polysaccharide-protein associations having pharmacological activity.
ES2027528A6 Process for obtaining polymers with antiviral activity.
ES2027527A6 Process for obtaining polymers with antiviral activity.
ES2020652A6 Production of natural oligosaccharide having tissue recovery promoting activity